AAAAAA

   
Results: 1-17 |
Results: 17
The therapeutic use of antibodies for malignancy
Authors: Johnson, PWM
Citation: Pwm. Johnson, The therapeutic use of antibodies for malignancy, TRANSF CL B, 8(3), 2001, pp. 255-259
BAG-1 immunostaining and survival in early breast cancer
Authors: Cutress, RI Townsend, PA Bateman, AC Johnson, PWM Ryder, K Barnes, DM Packham, G
Citation: Ri. Cutress et al., BAG-1 immunostaining and survival in early breast cancer, J CL ONCOL, 19(16), 2001, pp. 3706-3706
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer
Authors: Johnson, PWM Muers, MF Peake, MD Poulter, KM Gurney, EM Napp, V Hepburn, PM Brown, JM
Citation: Pwm. Johnson et al., A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer, BR J CANC, 84(1), 2001, pp. 19-24
FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma
Authors: Child, JA Johnson, SA Rule, S Smith, GM Morgan, GJ Johnson, PWM Prentice, AG Tollerfield, SM Wareham, E
Citation: Ja. Child et al., FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma, LEUK LYMPH, 37(3-4), 2000, pp. 309-317
Identification of a novel human BCL-X promoter and exon
Authors: MacCarthy-Morrogh, L Wood, L Brimmell, M Johnson, PWM Packham, G
Citation: L. Maccarthy-morrogh et al., Identification of a novel human BCL-X promoter and exon, ONCOGENE, 19(48), 2000, pp. 5534-5538
Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response
Authors: Foran, JM Cunningham, D Coiffier, B Solal-Celigny, P Reyes, F Ghielmini, M Johnson, PWM Gisselbrecht, C Bradburn, M Matthews, J Lister, TA
Citation: Jm. Foran et al., Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response, ANN ONCOL, 11, 2000, pp. 117-121
High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up
Authors: Apostolidis, J Gupta, RK Grenzelias, D Johnson, PWM Pappa, VI Summers, KE Salam, A Adams, K Norton, AJ Amess, JAL Matthews, J Bradburn, M Lister, TA Rohatiner, AZS
Citation: J. Apostolidis et al., High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up, J CL ONCOL, 18(3), 2000, pp. 527-536
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma
Authors: Foran, JM Rohatiner, AZS Cunningham, D Popescu, RA Solal-Celigny, P Ghielmini, M Coiffier, B Johnson, PWM Gisselbrecht, C Reyes, F Radford, JA Bessell, EM Souleau, B Benzohra, A Lister, TA
Citation: Jm. Foran et al., European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma, J CL ONCOL, 18(2), 2000, pp. 317-324
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests
Authors: Davies, FE Rawstron, AC Pratt, G Coupe, R Clarke, D Lubenko, A Short, K Perren, TJ Selby, PJ MacLennan, S Major, K Woodhead, V Robinson, F Child, JA Smith, GM Johnson, PWM Morgan, GJ
Citation: Fe. Davies et al., Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests, HEMATOL ONC, 18(3), 2000, pp. 111-120
Clinical trials of antibody therapy
Authors: Glennie, MJ Johnson, PWM
Citation: Mj. Glennie et Pwm. Johnson, Clinical trials of antibody therapy, IMMUNOL TOD, 21(8), 2000, pp. 403-410
Autologous stem cell transplantation for malignancy: a systematic review of the literature
Authors: Simnett, SJ Stewart, LA Sweetenham, J Morgan, G Johnson, PWM
Citation: Sj. Simnett et al., Autologous stem cell transplantation for malignancy: a systematic review of the literature, CLIN LAB H, 22(2), 2000, pp. 61-72
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue
Authors: Protheroe, AS Pickard, C Johnson, PWM Craddock, T Shefta, J Short, K Lancaster, F Selby, PJ Henwood, J Boylston, AW
Citation: As. Protheroe et al., Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue, BR J HAEM, 111(3), 2000, pp. 766-773
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response
Authors: Foran, JM Gupta, RK Cunningham, D Popescu, RA Goldstone, AH Sweetenham, JW Pettengell, R Johnson, PWM Bessell, E Hancock, B Summers, K Hughes, J Rohatiner, AZS Lister, TA
Citation: Jm. Foran et al., A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response, BR J HAEM, 109(1), 2000, pp. 81-88
The emerging role of radioimmunotherapy in haematological malignancies
Authors: Illidge, TM Johnson, PWM
Citation: Tm. Illidge et Pwm. Johnson, The emerging role of radioimmunotherapy in haematological malignancies, BR J HAEM, 108(4), 2000, pp. 679-688
Haemolytic uraemic syndrome following chemotherapy for an unusual germ-cell tumour
Authors: Mathur, RV Kumar, S Aparicio, S Johnson, PWM Newstead, CG
Citation: Rv. Mathur et al., Haemolytic uraemic syndrome following chemotherapy for an unusual germ-cell tumour, NEPH DIAL T, 14(7), 1999, pp. 1786-1788
Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study
Authors: Johnson, PWM Swinbank, K MacLennan, S Colomer, D Debuire, B Diss, T Gabert, J Gupta, RK Haynes, A Kneba, M Lee, MS Macintyre, E Mensink, E Moos, M Morgan, GJ Neri, A Johnson, A Reato, G Salles, G van 't Veer, MB Zehnder, JL Zucca, E Selby, PJ Cotter, FE
Citation: Pwm. Johnson et al., Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study, ANN ONCOL, 10(11), 1999, pp. 1349-1354
Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma
Authors: Apostolidis, J Foran, JM Johnson, PWM Norton, A Amess, J Matthews, J Bradburn, M Lister, TA Rohatiner, AZS
Citation: J. Apostolidis et al., Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma, J CL ONCOL, 17(1), 1999, pp. 216-221
Risultati: 1-17 |